Genetic susceptibility and loss of Nr4a1 enhances macrophage-mediated renal injury in CKD.
Nuclear hormone receptors of the NR4A subgroup have been implicated in cancer, atherosclerosis, and metabolic disease. However, little is known about the role of these receptors in kidney health or disease. Nr4a1-deficient rats (Nr4a1(-/-)) developed on a genetic background susceptible to kidney injury (fawn-hooded hypertensive rat [FHH]) were evaluated for BP, proteinuria, renal function, and metabolic parameters from 4 to 24 weeks-of-age. By week 24, Nr4a1(-/-) rats exhibited significantly higher proteinuria (approximately 4-fold) and decreased GFR compared with FHH controls. The severity of tubular atrophy, tubular casts, and interstitial fibrosis increased significantly in Nr4a1(-/-) rats and was accompanied by a large increase in immune cell infiltration, predominantly macrophages and to a lesser extent T cells and B cells. Global transcriptome and network analyses at weeks 8, 16, and 24 identified several proinflammatory genes and pathways differentially regulated between strains. Bone marrow crosstransplantation studies demonstrated that kidney injury in Nr4a1(-/-) rats was almost completely rescued by bone marrow transplanted from FHH controls. In vitro, macrophages isolated from Nr4a1(-/-) rats demonstrated increased immune activation compared with FHH-derived macrophages. In summary, the loss of Nr4a1 in immune cells appears to cause the increased kidney injury and reduced renal function observed in the Nr4a1(-/-) model.
Departments of Pharmacology and Toxicology.
Lindsey
L
Westbrook
Departments of Pharmacology and Toxicology.
Ashley C
AC
Johnson
Departments of Medicine and.
Kevin R
KR
Regner
Departments of Pharmacology and Toxicology, Medicine, and.
Jan M
JM
Williams
Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
David L
DL
Mattson
Pathology, University of Mississippi Medical Center, Jackson, Mississippi; and.
Patrick B
PB
Kyle
Pathology, University of Mississippi Medical Center, Jackson, Mississippi; and.
Jeffery R
JR
Henegar
Departments of Pharmacology and Toxicology, Medicine, and mrgarrett@umc.edu.
Michael R
MR
Garrett
D000818:Animals; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D004195:Disease Models, Animal; D008040:Genetic Linkage; D020022:Genetic Predisposition to Disease; D007678:Kidney Glomerulus / Q000276:immunology / Q000378:metabolism; D007684:Kidney Tubules / Q000276:immunology / Q000378:metabolism; D008264:Macrophages / Q000166:cytology / Q000276:immunology*; D008297:Male; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000235:genetics* / Q000276:immunology*; D011507:Proteinuria / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011919:Rats, Inbred Strains; D011922:Rats, Mutant Strains; D051436:Renal Insufficiency, Chronic / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D059467:Transcriptome
C539820:Nr4a1 protein, rat; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1